PEPTONIC medical AB (XSAT:PMED) FCF Margin %: -177.28% (As of Mar. 2026)


What is PEPTONIC medical AB FCF Margin %?

PEPTONIC medical AB XSAT:PMED -25.00% FCF Margin % is -177.28% as of Mar. 2026. The stock has 6 warning signs investors should review. Among 958 Drug Manufacturers companies, PEPTONIC medical AB ranks worse than 92.8% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. PEPTONIC medical AB's Free Cash Flow for the three months ended in Mar. 2026 was kr-5.56 Mil. PEPTONIC medical AB's Revenue for the three months ended in Mar. 2026 was kr3.14 Mil. Therefore, PEPTONIC medical AB's FCF Margin % for the quarter that ended in Mar. 2026 was -177.28%.

As of today, PEPTONIC medical AB's current FCF Yield % is -53.79%.

The historical rank and industry rank for PEPTONIC medical AB's FCF Margin % or its related term are showing as below:

XSAT:PMED' s FCF Margin % Range Over the Past 10 Years
Min: -4356.92   Med: -142.57   Max: -94.43
Current: -125.66

During the past 13 years, the highest FCF Margin % of PEPTONIC medical AB was -94.43%. The lowest was -4356.92%. And the median was -142.57%.

XSAT:PMED's FCF Margin % is ranked worse than
92.8% of 958 companies
in the Drug Manufacturers industry
Industry Median: 2.445 vs XSAT:PMED: -125.66

PEPTONIC medical AB FCF Margin % Related Terms

PEPTONIC medical AB FCF Margin % Historical Data

* Premium members only.

The historical data trend for PEPTONIC medical AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PEPTONIC medical AB FCF Margin % Chart

PEPTONIC medical AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -141.01 -94.43 -96.28 -144.13 -139.69

PEPTONIC medical AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -223.98 -56.15 -278.40 -65.05 -177.28

XSAT:PMED vs ZTS, UTHR, VTRS: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PEPTONIC medical AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PEPTONIC medical AB FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PEPTONIC medical AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where PEPTONIC medical AB's FCF Margin % falls into.


PEPTONIC medical AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

PEPTONIC medical AB's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-20.657/14.788
=-139.69 %

PEPTONIC medical AB's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-5.563/3.138
=-177.28 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -177.28% mean?
PEPTONIC medical AB (XSAT:PMED) has a FCF Margin % of -177.28% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on PEPTONIC medical AB and its competitors. According to the industry distribution chart, PEPTONIC medical AB ranks #889 out of 958 companies in the Drug Manufacturers industry, placing it in the top 92.8%.
Is PEPTONIC medical AB's FCF Margin % too high?
PEPTONIC medical AB's current FCF Margin % is -177.28%. Based on the distribution chart, PEPTONIC medical AB ranks #889 out of 958 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does PEPTONIC medical AB's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PEPTONIC medical AB ranks #889 out of 958 companies for FCF Margin %. This places PEPTONIC medical AB in the lower half of its industry. The industry median FCF Margin % is 2.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on PEPTONIC medical AB and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PEPTONIC medical AB's current FCF Margin % is -177.28%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PEPTONIC medical AB stock overvalued right now?
PEPTONIC medical AB (XSAT:PMED) has a current FCF Margin % of -177.28%. The current FCF Margin % is -177.28%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For PEPTONIC medical AB (XSAT:PMED), the current FCF Margin % is -177.28% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PEPTONIC medical AB Business Description

Address Gustavslundsvagen 143, Bromma, SWE, SE-167 51
PEPTONIC medical AB is a pharmaceutical company. It is engaged in developing oxytocin-based products for the treatment of menopausal symptoms, such as vaginal atrophy and vaginal dryness. Oxytocin is for medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women. The company is based in Sweden.